Baidu
map

2018中国微创外科专家行暨浙江省微创技术规范化巡讲在杭州启动

2018-01-29 MedSci MedSci原创

1月28日下午,由中国医师协会外科医师分会微创外科医师委员会、中华医学会外科学分会腹腔镜与内镜外科学组、浙江省微创技术质控中心、浙江省医学会微创外科学分会和浙江省医师协会微创外科专业委员会主办,《中国实用外科杂志》学术支持,北京泰德制药股份有限公司协办的“2018中国微创外科专家行暨浙江省微创技术规范化巡讲启动会”在杭州召开。 2018中国微创外科专家行暨浙江省微创技术规范化巡讲启动仪式

1月28日下午,由中国医师协会外科医师分会微创外科医师委员会、中华医学会外科学分会腹腔镜与内镜外科学组、浙江省微创技术质控中心、浙江省医学会微创外科学分会和浙江省医师协会微创外科专业委员会主办,《中国实用外科杂志》学术支持,北京泰德制药股份有限公司协办的“2018中国微创外科专家行暨浙江省微创技术规范化巡讲启动会”在杭州召开。

2018中国微创外科专家行暨浙江省微创技术规范化巡讲启动仪式

微创技术是21世纪外科的发展方向,相对于传统技术,微创技术以最小的创伤达到最大的治疗效果,深受广大医生及患者推崇,极大地提高了患者的治疗效果和生活质量,目前在我国各个医院广泛开展。

但微创医疗资源分布严重不均衡,优质资源过度地集中在大城市的大医院,越往基层拥有的医疗资源就越少,且微创外科医师的入门起点参差不齐、培训经历不同,这使得各个医师的水平差别较大。要提高微创技术实施的安全与质量,首先必须提升微创外科医生的专业水平,不仅要注重手术数量和技术操作,更要重视诊疗规范和手术质量。此外,围手术期管理措施到位与否对患者康复也至关重要,因此除手术本身外,还要加强围手术期的规范管理。在此背景下,“2018中国微创外科专家行”项目应运而生。

为促进中国微创技术的普及与发展,促进基层临床医师临床技术与操作水平的提高提供学习与交流的平台,“2018中国微创外科专家行”项目将在华北、华东、华南地区分别设立3家医院作为微创外科规范化培训基地,为全国微创外科中青年医师提供规范化培训。与此同时,“2018中国微创外科专家行”项目还会走进西部,为西部地区的中青年医师提供更多学习机会。

2018中国微创外科专家行”将通过授课、手术操作演示、手术视频讲解等形式进行巡讲,传递微创技术理念,规范微创技术发展,加强微创技术质控,以提升全国各医院微创技术的水平。“浙江省微创技术规范化巡讲”也将依托于“2018中国微创外科专家行”,在浙江省内开展系列巡讲活动,以提高省内各地区医生的微创诊疗水平。

蔡秀军教授

项目牵头人、中国医师协会外科医师分会微创外科医师委员会主任委员、浙江大学医学院附属邵逸夫医院院长蔡秀军教授指出,微创外科经过30年的发展,在国内已经非常普及,但距离我国提出的高质量发展还有差距,仍存在诊疗不规范的问题。希望通过专家行活动和质控中心的工作,规范微创技术的准入与开放,提高浙江省乃至全国范围微创外科医师的技术,促进微创外科的普及与发展。

仇明教授

中华医学会外科学分会腹腔镜与内镜外科学组副组长、上海长征医院仇明教授表示,虽然我国腹腔镜外科技术目前已处于国际领先水平,但仍存在很多不足。该项目的开展将促进我国微创外科技术更加平衡的发展,缩小不同地区之间的差异,让更多患者获益。

俞新乐处长

浙江省卫生计生委管处处长俞新乐提出,我国微创技术的发展存在三个不平衡:技术的进步与理念的更新不平衡、技术推广与质量管理不平衡和技术应用区域不平衡。希望能借助该项目平台,集各医院和专家之所长,消除我国不同地区和医院微创技术发展的不平衡,切实提高诊治水平。

与会专家合影

启动会后还召开了浙江省微创技术质控工作会暨浙江省微创质控中心专家委员会会议、浙江省医学会微创外科学分会委员扩大会议、浙江省医师协会微创外科专业委员会全体会议

参加此次会议的还有《中国实用外科杂志》主编田利国主任以及我国著名微创外科专家中山大学孙逸仙纪念医院陈亚进教授、广东省人民医院志祥教授、浙江大学医学院附属邵逸夫医院虞洪教授、大连医科大学附属第二医院王立明教授、天津市肿瘤医院宋天强教授复旦大学附属肿瘤医院王鲁教授等。浙江大学医学院附属邵逸夫医院梁霄教授担任会议主持。

会场掠影

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1927137, encodeId=4a39192e137f8, content=<a href='/topic/show?id=7dcd54891d1' target=_blank style='color:#2F92EE;'>#技术规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54891, encryptionId=7dcd54891d1, topicName=技术规范)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Thu Oct 04 21:39:00 CST 2018, time=2018-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691367, encodeId=f3e7169136e59, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=869a29217831, createdName=windight, createdTime=Mon May 14 02:39:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317022, encodeId=6f48131e022e9, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Wed Jan 31 08:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554130, encodeId=d285155413063, content=<a href='/topic/show?id=5ccb5051e37' target=_blank style='color:#2F92EE;'>#微创外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50517, encryptionId=5ccb5051e37, topicName=微创外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7af914505846, createdName=liuyong2985, createdTime=Wed Jan 31 08:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=283265, encodeId=69ac2832659f, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Jan 29 18:33:46 CST 2018, time=2018-01-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1927137, encodeId=4a39192e137f8, content=<a href='/topic/show?id=7dcd54891d1' target=_blank style='color:#2F92EE;'>#技术规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54891, encryptionId=7dcd54891d1, topicName=技术规范)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Thu Oct 04 21:39:00 CST 2018, time=2018-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691367, encodeId=f3e7169136e59, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=869a29217831, createdName=windight, createdTime=Mon May 14 02:39:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317022, encodeId=6f48131e022e9, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Wed Jan 31 08:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554130, encodeId=d285155413063, content=<a href='/topic/show?id=5ccb5051e37' target=_blank style='color:#2F92EE;'>#微创外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50517, encryptionId=5ccb5051e37, topicName=微创外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7af914505846, createdName=liuyong2985, createdTime=Wed Jan 31 08:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=283265, encodeId=69ac2832659f, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Jan 29 18:33:46 CST 2018, time=2018-01-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1927137, encodeId=4a39192e137f8, content=<a href='/topic/show?id=7dcd54891d1' target=_blank style='color:#2F92EE;'>#技术规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54891, encryptionId=7dcd54891d1, topicName=技术规范)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Thu Oct 04 21:39:00 CST 2018, time=2018-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691367, encodeId=f3e7169136e59, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=869a29217831, createdName=windight, createdTime=Mon May 14 02:39:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317022, encodeId=6f48131e022e9, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Wed Jan 31 08:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554130, encodeId=d285155413063, content=<a href='/topic/show?id=5ccb5051e37' target=_blank style='color:#2F92EE;'>#微创外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50517, encryptionId=5ccb5051e37, topicName=微创外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7af914505846, createdName=liuyong2985, createdTime=Wed Jan 31 08:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=283265, encodeId=69ac2832659f, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Jan 29 18:33:46 CST 2018, time=2018-01-29, status=1, ipAttribution=)]
    2018-01-31 vera_1203
  4. [GetPortalCommentsPageByObjectIdResponse(id=1927137, encodeId=4a39192e137f8, content=<a href='/topic/show?id=7dcd54891d1' target=_blank style='color:#2F92EE;'>#技术规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54891, encryptionId=7dcd54891d1, topicName=技术规范)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Thu Oct 04 21:39:00 CST 2018, time=2018-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691367, encodeId=f3e7169136e59, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=869a29217831, createdName=windight, createdTime=Mon May 14 02:39:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317022, encodeId=6f48131e022e9, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Wed Jan 31 08:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554130, encodeId=d285155413063, content=<a href='/topic/show?id=5ccb5051e37' target=_blank style='color:#2F92EE;'>#微创外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50517, encryptionId=5ccb5051e37, topicName=微创外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7af914505846, createdName=liuyong2985, createdTime=Wed Jan 31 08:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=283265, encodeId=69ac2832659f, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Jan 29 18:33:46 CST 2018, time=2018-01-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1927137, encodeId=4a39192e137f8, content=<a href='/topic/show?id=7dcd54891d1' target=_blank style='color:#2F92EE;'>#技术规范#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54891, encryptionId=7dcd54891d1, topicName=技术规范)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Thu Oct 04 21:39:00 CST 2018, time=2018-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691367, encodeId=f3e7169136e59, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=869a29217831, createdName=windight, createdTime=Mon May 14 02:39:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317022, encodeId=6f48131e022e9, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Wed Jan 31 08:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554130, encodeId=d285155413063, content=<a href='/topic/show?id=5ccb5051e37' target=_blank style='color:#2F92EE;'>#微创外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50517, encryptionId=5ccb5051e37, topicName=微创外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7af914505846, createdName=liuyong2985, createdTime=Wed Jan 31 08:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=283265, encodeId=69ac2832659f, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Mon Jan 29 18:33:46 CST 2018, time=2018-01-29, status=1, ipAttribution=)]
    2018-01-29 131****1460

    学习了受益匪浅

    0

相关资讯

微创外科

微创外科

新技术圆百岁骨折老人行走梦

去年12月26日,江苏省镇江市第一人民医院骨科成功为一名103岁患者实施微创髋关节置换术,患者当天下午便可自行站立,术后恢复良好,这也是目前国内使用SuperPath?微创伤后入路全髋关节置换技术(以下简称“SuperPath?”)成功治愈患者中年龄最高的一位。

沉痛悼念减重外科创始人——郑成竹教授!

沉痛悼念我国微创外科开拓者、减重外科创始人,著名外科专家,上海长海医院郑成竹教授,于2017年2月27日22:38,因病医治无效,永远离开了我们!享年57岁!郑成竹教授是中国人民解放军第二军医大学附属长海医院外科教授、主任医师、博士生导师。郑成竹教授生前担任亚太地区手术治疗肥胖症外科学会常委、亚太地区(中国)肥胖症诊疗中心主任、亚洲内镜外科学会常委、中华医学会外科分会委员、中华医学会内分泌外科学组

Bruno:胃癌的微创外科治疗

第九届全国胃癌学术会议上, 第11届世界胃癌大会(IGCC2015)的大会主席、来自巴西圣保罗大学的Bruno Zilberstein 教授介绍了巴西的胃癌微创外科治疗。在西方国家,初诊胃癌患者多为进展期胃癌,而在东方国家,50%左右的初诊患者为早期胃癌。到目前为止,手术治疗是治疗胃癌行之有效的手段,放化疗等其他治疗方法的目的是在于改善手术患者的预后或姑息治疗。自Goh等完成第一例腹腔镜辅助胃切除

Baidu
map
Baidu
map
Baidu
map